SCHEMBL15908554

SCHEMBL15908554

CC(C)CCn1c(Cn2c(=O)cnc3ccc(F)cc32)nc2nc(Cl)ccc21

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 4/20 0.34
CYP3A4 P08684 4/20 0.34
TSHR P16473 4/20 0.34
CYP2C19 P33261 3/20 0.34
ALDH1A1 P00352 3/20 0.34
HSD17B10 Q99714 3/20 0.34
CYP2C9 P11712 2/20 0.34
CASP1 P29466 2/20 0.34
CASP7 P55210 2/20 0.34
CYP2D6 P10635 1/20 0.34
HPGD P15428 1/20 0.34
CNR2 P34972 2/20 0.33
GRM2 Q14416 1/20 0.33
BRD4 O60885 1/20 0.33
USP2 O75604 1/20 0.33
LMNA P02545 1/20 0.33
GLA P06280 1/20 0.33
MAPK1 P28482 1/20 0.33
HIF1A Q16665 1/20 0.33
CLK4 Q9HAZ1 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15908559 0.93 CNR2 (0.36) CYP1A2CYP3A4TSHRCYP2C19ALDH1A1
SCHEMBL15908553 0.93 GRIN2B (0.37) CYP1A2CYP3A4TSHRCYP2C19ALDH1A1
SCHEMBL15908533 0.89 CNR2 (0.33) TSHRCNR2MAPK1
SCHEMBL15908539 0.85 SPHK1 (0.35) TSHRCNR2MAPK1GRIN2B
SCHEMBL15908538 0.85 PDE5A (0.39) GRIN2B
SCHEMBL15908537 0.83 SPHK1 (0.34) CNR2GRIN2B
SCHEMBL15908562 0.83 TSHR (0.36) TSHRCNR2BRD4MAPK1
SCHEMBL9978103 0.79 CYP3A4 (0.36) CYP3A4TSHRGRM2
SCHEMBL15908534 0.77 HSP90AA1 (0.38) ALDH1A1CNR2
SCHEMBL15553842 0.76 PARG (0.42) TSHRALDH1A1USP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20190023692-A1 QUINOXALINONES AND DIHYDROQUINOXALINONES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS JANSSEN SCIENCES IRELAND UC (IE) 2019-01-24 US disclosed
US-20170260166-A1 QUINOXALINONES AND DIHYDROQUINOXALINONES AS RESPIRATORY SYNCYTIAL VIRUS ATIVIRAL AGENTS JANSSEN INFECTIOUS DISEASES BVBA (BE) 2017-09-14 US disclosed
US-20170260166-A1 QUINOXALINONES AND DIHYDROQUINOXALINONES AS RESPIRATORY SYNCYTIAL VIRUS ATIVIRAL AGENTS JANSSEN INFECTIOUS DISEASES BVBA (BE) 2017-09-14 US disclosed
EP-2948444-B1 QUINOXALINONES AND DIHYDROQUINOXALINONES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS JANSSEN SCIENCES IRELAND UC (IE) 2016-12-07 EP disclosed
WO-2014114776-A1 QUINOXALINONES AND DIHYDROQUINOXALINONES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS JANSSEN R&D IRELAND (IE) 2014-07-31 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190023692-A1 QUINOXALINONES AND DIHYDROQUINOXALINONES AS RESPIRATORY SYNCYTIAL VIRUS ANTIVIRAL AGENTS SQOR, SDHA, DHX15 CYP1A2 1032/4885CYP3A4 341/4885TSHR 4855/4885
US-20170260166-A1 QUINOXALINONES AND DIHYDROQUINOXALINONES AS RESPIRATORY SYNCYTIAL VIRUS ATIVIRAL AGENTS ATIC, DHX15, SQOR CYP1A2 711/4885CYP3A4 364/4885TSHR 4847/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.